Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Plos One|June 21, 2011
Mycobacterium tuberculosis acg gene is required for growth and virulence in vivoYanmin Hu, Anthony R M CoatesHandbook of Experimental Pharmacology|October 24, 2012
Antibiotics in phase II and III clinical trialsAnthony R M Coates, Gerry HallsTrends in Pharmacological Sciences|February 12, 2008
Targeting non-multiplying organisms as a way to develop novel antimicrobialsAnthony R M Coates, Yanmin HuDrugs in R&D|June 7, 2006
New strategies for antibacterial drug design: targeting non-multiplying latent bacteriaAnthony R M Coates, Yanmin HuPlos One|April 3, 2009
Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpXYanmin Hu, Anthony R M CoatesBritish Journal of Pharmacology|August 21, 2007
Novel approaches to developing new antibiotics for bacterial infectionsA R M Coates, Y HuFEMS Microbiology Letters|January 26, 2005
Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coliYanmin Hu, Anthony R M CoatesThe Journal of Antimicrobial Chemotherapy|October 9, 2012
Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studiesYanmin Hu, Anthony R M CoatesCurrent Pharmaceutical Design|November 17, 2004
Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugsDenis A Mitchison, Anthony R M CoatesBritish Journal of Pharmacology|February 18, 2011
Novel classes of antibiotics or more of the same?Anthony R M Coates, Gerry Halls, Yanmin HuPageof 8